milrinone has been researched along with Diabetes Mellitus, Adult-Onset in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Levosimendan was more efficient than milrinone for treating the hemodynamic manifestations of the postcardiopulmonary bypass low-output syndrome." | 2.72 | Levosimendan or milrinone in the type 2 diabetic patient with low ejection fraction undergoing elective coronary artery surgery. ( Al-Shawaf, E; Ayed, A; Dehrab, N; Radomir, B; Tarazi, R; Vislocky, I, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Shawaf, E | 1 |
| Ayed, A | 1 |
| Vislocky, I | 1 |
| Radomir, B | 1 |
| Dehrab, N | 1 |
| Tarazi, R | 1 |
1 trial available for milrinone and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
Levosimendan or milrinone in the type 2 diabetic patient with low ejection fraction undergoing elective coronary artery surgery.
Topics: Adult; Aged; Blood Pressure; Cardiac Output, Low; Cardiopulmonary Bypass; Coronary Artery Bypass; Di | 2006 |